ALPS ETF Trust (SBIO)
Verwaltungsgesellschaft · ARCX · Serie S000047823 · Auf SEC EDGAR ansehen ↗
- Nettovermögen
- $161.8M
- Bestände
- 89
- Stand
- 31. Mai 2026
- Gewichtung der Top-10-Positionen
- 34,80%
- Effektive Anzahl von Positionen
- 46,8
- Positionen über 1%
- 40
Auf dieser Seite
- Fondstransaktionen Geld, das jeden Monat in den Fonds fließt und aus ihm abfließt, aus N-PORT-Einreichungen.
- Bestände Jede Position, die der Fonds derzeit hält, mit Gewichtungen.
- Sektoraufschlüsselung Aufteilung der Fondsbestände nach Sektoren.
- Institutionelle Eigentümer 13F-Institutionen, die angeben, diesen ETF zu halten.
- Ähnliche Fonds Andere Fonds mit überlappenden Beständen oder vergleichbarer Größe.
Fondsflüsse (SEC-gemeldet)
- Letzter Monat (Mai 2026)
- +$4.1M
- Quartalsende Mai 2026
- +$17.5M
- Letzte 12 Monate
- +$23.5M
Jun 2025 – Mai 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Vollständige Zusammensetzung 89 Beteiligungen
| Name | CUSIP | Wert | % | Bilanz | Kategorie | Land |
|---|---|---|---|---|---|---|
| Alkermes Plc | G01767105 | $7.2M | 4,48 | 171.723 | EC | IE |
| Kymera Therapeutics Inc | 501575104 | $6.9M | 4,23 | 84.154 | EC | US |
| Celcuity Inc | 15102K100 | $6.3M | 3,92 | 47.693 | EC | US |
| Mirum Pharmaceuticals Inc | 604749101 | $6.3M | 3,90 | 62.199 | EC | US |
| Spyre Therapeutics Inc | 00773J202 | $6.0M | 3,68 | 80.958 | EC | US |
| Cg Oncology Inc | 156944100 | $5.4M | 3,35 | 87.032 | EC | US |
| Apogee Therapeutics Inc | 03770N101 | $4.7M | 2,93 | 57.722 | EC | US |
| Xenon Pharmaceuticals Inc | 98420N105 | $4.7M | 2,90 | 85.746 | EC | CA |
| Travere Therapeutics Inc | 89422G107 | $4.5M | 2,77 | 95.051 | EC | US |
| Dianthus Therapeutics Inc | 252828108 | $4.3M | 2,64 | 45.839 | EC | US |
| Newamsterdam Pharma Co Nv | N62509109 | $4.0M | 2,47 | 118.514 | EC | NL |
| Viking Therapeutics Inc | 92686J106 | $3.9M | 2,41 | 119.108 | EC | US |
| Crinetics Pharmaceuticals Inc | 22663K107 | $3.8M | 2,37 | 107.892 | EC | US |
| Acadia Pharmaceuticals Inc | 004225108 | $3.8M | 2,35 | 175.740 | EC | US |
| Edgewise Therapeutics Inc | 28036F105 | $3.8M | 2,33 | 110.576 | EC | US |
| Denali Therapeutics Inc | 24823R105 | $3.4M | 2,13 | 163.467 | EC | US |
| Oruka Therapeutics Inc | 687604108 | $2.9M | 1,81 | 49.896 | EC | US |
| Structure Therapeutics Inc | 86366E106 | $2.9M | 1,78 | 73.020 | EC | KY |
| Disc Medicine Inc | 254604101 | $2.7M | 1,69 | 39.334 | EC | US |
| Ideaya Biosciences Inc | 45166A102 | $2.7M | 1,65 | 90.520 | EC | US |
| Vera Therapeutics Inc | 92337R101 | $2.6M | 1,61 | 73.552 | EC | US |
| Tarsus Pharmaceuticals Inc | 87650L103 | $2.6M | 1,61 | 43.870 | EC | US |
| Relay Therapeutics Inc | 75943R102 | $2.6M | 1,60 | 184.224 | EC | US |
| Mineralys Therapeutics Inc | 603170101 | $2.6M | 1,59 | 81.578 | EC | US |
| Celldex Therapeutics Inc | 15117B202 | $2.2M | 1,33 | 68.615 | EC | US |
| Zai Lab Ltd | 98887Q104 | $2.0M | 1,26 | 115.031 | EC | KY |
| Pharvaris Nv | N69605108 | $2.0M | 1,23 | 66.026 | EC | NL |
| Sionna Therapeutics Inc | 829401108 | $2.0M | 1,23 | 46.379 | EC | US |
| Rapport Therapeutics Inc | 75383L102 | $1.9M | 1,20 | 49.264 | EC | US |
| Sarepta Therapeutics Inc | 803607100 | $1.9M | 1,20 | 108.222 | EC | US |
| Lakefront Biotherapeutics Nv | 36315X101 | $1.9M | 1,19 | 67.945 | EC | BE |
| Tyra Biosciences Inc | 90240B106 | $1.9M | 1,15 | 55.509 | EC | US |
| Novavax Inc | 670002401 | $1.8M | 1,14 | 167.949 | EC | US |
| Stoke Therapeutics Inc | 86150R107 | $1.8M | 1,12 | 58.873 | EC | US |
| Agios Pharmaceuticals Inc | 00847X104 | $1.8M | 1,10 | 60.392 | EC | US |
| Vericel Corp | 92346J108 | $1.7M | 1,08 | 52.309 | EC | US |
| Nuvation Bio Inc | 67080N101 | $1.7M | 1,06 | 357.260 | EC | US |
| Palvella Therapeutics Inc | 697947109 | $1.7M | 1,03 | 14.096 | EC | US |
| Taysha Gene Therapies Inc | 877619106 | $1.7M | 1,02 | 282.348 | EC | US |
| Amylyx Pharmaceuticals Inc | 03237H101 | $1.6M | 1,01 | 113.933 | EC | US |
| Immatics Nv | N44445109 | $1.6M | 0,98 | 138.190 | EC | NL |
| Immunocore Holdings Plc | 45258D105 | $1.5M | 0,93 | 52.254 | EC | GB |
| Mbx Biosciences Inc | 55287L101 | $1.5M | 0,90 | 46.286 | EC | US |
| Bicara Therapeutics Inc | 055477103 | $1.4M | 0,88 | 65.313 | EC | US |
| Moonlake Immunotherapeutics | 61559X104 | $1.4M | 0,88 | 73.934 | EC | KY |
| Kalvista Pharmaceuticals Inc | 483497103 | $1.4M | 0,87 | 52.105 | EC | US |
| Arrivent Biopharma Inc | 04272N102 | $1.4M | 0,85 | 45.563 | EC | US |
| Oculis Holding Ag | H5870P102 | $1.4M | 0,84 | 58.929 | EC | CH |
| Maze Therapeutics Inc | 578784100 | $1.3M | 0,81 | 49.602 | EC | US |
| Mannkind Corp | 56400P706 | $1.2M | 0,74 | 317.578 | EC | US |
Seite 1
von 2
← Zurück
Weiter →
Sektoraufschlüsselung
Healthcare
100,0%
Institutionelle Eigentümer (13F) 70 Einreicher
Institutionen, die diese ETF in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann zweimal für separate Optionskontrakte erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Institution | Wert | % der verfolgten 13F | Aktien | Typ | Stand |
|---|---|---|---|---|---|
| UBS Group AG | $11.559.355 | 21,86% | 178.799 | Aktien | 30. Juni 2026 |
| BANK OF AMERICA CORP /DE/ | $7.127.892 | 13,48% | 110.254 | Aktien | 30. Juni 2026 |
| CONNORS INVESTOR SERVICES INC | $3.112.057 | 5,89% | 48.137 | Aktien | 30. Juni 2026 |
| LPL Financial LLC | $2.437.279 | 4,61% | 37.700 | Aktien | 30. Juni 2026 |
| Moran Wealth Management, LLC | $2.200.040 | 4,16% | 34.030 | Aktien | 30. Juni 2026 |
| WELLS FARGO & COMPANY/MN | $1.945.817 | 3,68% | 30.098 | Aktien | 30. Juni 2026 |
| GRIFFIN ASSET MANAGEMENT, INC. | $1.855.390 | 3,51% | 28.699 | Aktien | 30. Juni 2026 |
| STIFEL FINANCIAL CORP | $1.658.181 | 3,14% | 25.648 | Aktien | 30. Juni 2026 |
| Sterling Investment Advisors, Ltd. | $1.538.670 | 2,91% | 23.800 | Aktien | 30. Juni 2026 |
| RAYMOND JAMES FINANCIAL INC | $1.469.624 | 2,78% | 22.732 | Aktien | 30. Juni 2026 |
| SILVER OAK SECURITIES, INCORPORATED | $1.336.962 | 2,53% | 20.680 | Aktien | 30. Juni 2026 |
| Strategic Financial Services, Inc. | $1.301.643 | 2,46% | 24.869 | Aktien | 31. März 2026 |
| NTV Asset Management LLC | $1.104.416 | 2,09% | 17.083 | Aktien | 30. Juni 2026 |
| Equitable Holdings, Inc. | $990.891 | 1,87% | 15.327 | Aktien | 30. Juni 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $844.140 | 1,60% | 13.057 | Aktien | 30. Juni 2026 |
| BOK Financial Private Wealth, Inc. | $840.450 | 1,59% | 13.000 | Aktien | 30. Juni 2026 |
| ELEVATION POINT WEALTH PARTNERS, LLC | $725.696 | 1,37% | 11.225 | Aktien | 30. Juni 2026 |
| ROYAL BANK OF CANADA | $723.000 | 1,37% | 11.181 | Aktien | 30. Juni 2026 |
| DAVENPORT & Co LLC | $717.615 | 1,36% | 11.100 | Aktien | 30. Juni 2026 |
| Vestmark Advisory Solutions, Inc. | $575.256 | 1,09% | 8.898 | Aktien | 30. Juni 2026 |
| Prospera Financial Services Inc | $573.485 | 1,08% | 8.872 | Aktien | 30. Juni 2026 |
| Phoenix Wealth Advisors | $542.414 | 1,03% | 8.390 | Aktien | 30. Juni 2026 |
| Kestra Advisory Services, LLC | $535.414 | 1,01% | 8.282 | Aktien | 30. Juni 2026 |
| Savant Capital, LLC | $526.759 | 1,00% | 8.035 | Aktien | 30. Juni 2026 |
| McGuire Investment Group, LLC | $488.108 | 0,92% | 7.550 | Aktien | 30. Juni 2026 |
| BROWN ADVISORY INC | $468.712 | 0,89% | 7.250 | Aktien | 30. Juni 2026 |
| MSH Capital Advisors LLC | $461.601 | 0,87% | 7.140 | Aktien | 30. Juni 2026 |
| OSAIC HOLDINGS, INC. | $451.097 | 0,85% | 6.980 | Aktien | 30. Juni 2026 |
| EXENCIAL WEALTH ADVISORS, LLC | $414.941 | 0,78% | 8.101 | Aktien | 31. Dezember 2025 |
| INDEPENDENT FINANCIAL GROUP, LLC | $400.162 | 0,76% | 6.190 | Aktien | 30. Juni 2026 |
| TWO SIGMA INVESTMENTS, LP | $387.900 | 0,73% | 6.000 | Aktien | 30. Juni 2026 |
| Steward Partners Investment Advisory, LLC | $353.506 | 0,67% | 5.468 | Aktien | 30. Juni 2026 |
| BlackDiamond Wealth Management, LLC | $341.104 | 0,65% | 5.082 | Aktien | 30. Juni 2026 |
| Jaffetilchin Investment Partners, LLC | $339.791 | 0,64% | 6.492 | Aktien | 31. März 2026 |
| Farther Finance Advisors, LLC | $321.828 | 0,61% | 4.978 | Aktien | 30. Juni 2026 |
| Retirement Planning Co of New England, Inc. | $286.904 | 0,54% | 4.438 | Aktien | 30. Juni 2026 |
| Intrepid Financial Planning Group LLC | $267.586 | 0,51% | 4.139 | Aktien | 30. Juni 2026 |
| Fulcrum Equity Management | $263.395 | 0,50% | 4.074 | Aktien | 30. Juni 2026 |
| Keystone Financial Group | $258.600 | 0,49% | 4.000 | Aktien | 30. Juni 2026 |
| Ally Invest Advisors Inc. | $231.522 | 0,44% | 3.581 | Aktien | 30. Juni 2026 |
| Cherry Creek Investment Advisors, Inc. | $222.849 | 0,42% | 3.447 | Aktien | 30. Juni 2026 |
| CDKV HOLDINGS LLC | $166.797 | 0,32% | 2.580 | Aktien | 30. Juni 2026 |
| AllSquare Wealth Management LLC | $81.293 | 0,15% | 2.092 | Aktien | 30. September 2025 |
| Ashton Thomas Private Wealth, LLC | $70.210 | 0,13% | 1.086 | Aktien | 30. Juni 2026 |
| Rockefeller Capital Management L.P. | $66.901 | 0,13% | 1.034 | Aktien | 30. Juni 2026 |
| MGB Wealth Management, LLC | $51.220 | 0,10% | 1.000 | Aktien | 31. Dezember 2025 |
| MORGAN STANLEY | $42.540 | 0,08% | 658 | Aktien | 30. Juni 2026 |
| US BANCORP \DE\ | $41.699 | 0,08% | 645 | Aktien | 30. Juni 2026 |
| HARBOR INVESTMENT ADVISORY, LLC | $29.093 | 0,06% | 450 | Aktien | 30. Juni 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $18.319 | 0,03% | 350 | Aktien | 31. März 2026 |
| PNC Financial Services Group, Inc. | $17.132 | 0,03% | 265 | Aktien | 30. Juni 2026 |
| Arax Advisory Partners | $13.577 | 0,03% | 210 | Aktien | 30. Juni 2026 |
| Axiom Investment Management LLC | $11.637 | 0,02% | 180 | Aktien | 30. Juni 2026 |
| Aptus Capital Advisors, LLC | $11.637 | 0,02% | 180 | Aktien | 30. Juni 2026 |
| Asset Dedication, LLC | $10.797 | 0,02% | 167 | Aktien | 30. Juni 2026 |
| First Command Advisory Services, Inc. | $6.465 | 0,01% | 100 | Aktien | 30. Juni 2026 |
| BANK OF MONTREAL /CAN/ | $6.465 | 0,01% | 100 | Aktien | 30. Juni 2026 |
| Salomon & Ludwin, LLC | $6.335 | 0,01% | 100 | Aktien | 30. Juni 2026 |
| Institute for Wealth Management, LLC. | $4.267 | 0,01% | 66 | Aktien | 30. Juni 2026 |
| Global Retirement Partners, LLC | $3.879 | 0,01% | 60 | Aktien | 30. Juni 2026 |
| Pinnacle Wealth Planning Services, Inc. | $3.814 | 0,01% | 59 | Aktien | 30. Juni 2026 |
| Spire Wealth Management | $3.426 | 0,01% | 53 | Aktien | 30. Juni 2026 |
| AE Wealth Management LLC | $970 | 0,00% | 15 | Aktien | 30. Juni 2026 |
| CWM, LLC | $785 | 0,00% | 15 | Aktien | 31. März 2026 |
| Triumph Capital Management | $646 | 0,00% | 10 | Aktien | 30. Juni 2026 |
| Physician Wealth Advisors, Inc. | $640 | 0,00% | 10 | Aktien | 30. Juni 2026 |
| Cambridge Investment Research Advisors, Inc. | $567 | 0,00% | 8.774 | Aktien | 30. Juni 2026 |
| FIDUCIARY FINANCIAL ADVISORS | $268 | 0,00% | 4 | Aktien | 30. Juni 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | $65 | 0,00% | 1 | Aktien | 30. Juni 2026 |
| Motiv8 Investments LLC | $3 | 0,00% | 60 | Aktien | 31. Dezember 2025 |
Vergleichsfonds
Mehr von diesem Emittenten
Ähnlich in der Größe
| Fonds | AuM |
|---|---|
| AFMC First Trust Exchange-Traded Fun… | $161.9M |
| AVMU AMERICAN CENTURY ETF TRUST | $162.0M |
| LDSF First Trust Exchange-Traded Fun… | $162.1M |
| NORW Global X Funds | $162.2M |
| IHYF Invesco Actively Managed Exchan… | $162.5M |
| BUFS First Trust Exchange-Traded Fun… | $161.6M |
| PRCS Parnassus Funds II | $161.0M |
| IDRV iShares Trust | $160.8M |
| EMXF iShares Trust | $160.7M |
| PSH PGIM ETF Trust | $160.6M |